Auris Health, Inc. Company Profile

11:39 EST 23rd January 2019 | BioPortfolio

Based in Silicon Valley, Auris Health is pioneering the next era of medical intervention by developing platforms that enhance physician capabilities, evolve minimally invasive techniques, and create new categories of care that redefine optimal patient outcomes. The company is committed to transforming medical intervention by integrating robotics, micro-instrumentation, endoscope design, sensing, and data science into one platform. Every element of our technology is driven by patient-specific design aimed at maintaining the integrity of the human body. The company is backed by leading technology investors including Mithril Capital Management, Lux Capital, Coatue Management, and Highland Capital. Learn more at

News Articles [253 Associated News Articles listed on BioPortfolio]

Auris Health Lands $220M to Expand Sales of Lung Testing Medical Robot

Auris Health has already received regulatory clearance to sell its medical robot in the U.S. Now it has $220 million in funding to help it place the technology in the hands of surgeons. The latest inv...

Auris Health gets $220M boost

A round of financing led by Partner Fund Management has brought in $220 million for Auris Health, which will use the funds to -More- 

Auris Health secures $220m funds to advance medical robotics platform

Auris Health has received funding under the financing round led by Partner Fund Management. New investors such as Wellington Management, D1 Capital Partners and Senator Investment Group and The post ...

Bruker Expands Portfolio for Testing of Candida Auris, an Emerging, Multidrug-Resistant Pathogen in Human Healthcare

New Fungiplex™ Candida Auris PCR Assay for Hygiene and Infection Control (RuO) - New MALDI Biotyper® Diagnostic Workflow for C. Auris Identification. At the International Society for Human a...

[Articles] Multiple introductions and subsequent transmission of multidrug-resistant Candida auris in the USA: a molecular epidemiological survey

Isolates of C auris in the USA were genetically related to those from four global regions, suggesting that C auris was introduced into the USA several times. The five travel-related cases are examples...

Auris Health raises $220mm in Series E funding round

Auris Health Inc. (formerly Auris Surgical Robotics) raised $220mm through what appears to be its Series E round led by Partner Fund Management. New investors Wellington Management, D1 Capital Partner...

Auris Medical Announces Results of Pre-IND Meeting With FDA For AM-201 Program

Auris Medical (NASDAQ:EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and mental health supportive care, today announced ...

Auris Medical Holding (EARS) - Q318 results and business updates

Edison Investment Research - Pharmaceutical & healthcare - Auris Medical Holding: Auris Medical recently reported its Q318 results and provided a brief business update on its active programs. R&D ...

PubMed Articles [3513 Associated PubMed Articles listed on BioPortfolio]

A Candida auris Outbreak and Its Control in an Intensive Care Setting.

Candida auris is an emerging and multidrug-resistant pathogen. Here we report the epidemiology of a hospital outbreak of C. auris colonization and infection.

Candida auris: Epidemiology, risk factors, virulence, resistance, and therapeutic options.

Candida auris emerged as a pathogen resistant to multiple antifungal and has been associated with nosocomial outbreaks with high transmission capacity between hospitalized individuals. C. auris was fi...

Phenotypic switching in newly emerged multidrug-resistant pathogen Candida auris.

Candida auris is an emerging, multidrug-resistant yeast that can spread rapidly in healthcare settings. Phenotypic switching has been observed in other Candida species and can potentially interfere wi...

Invasive Candida auris infections in Kuwait hospitals: epidemiology, antifungal treatment and outcome.

Candida auris is a recently recognized yeast pathogen, which has attracted worldwide attention due to its multidrug-resistant nature and associated high mortality rates. Its persistence in hospital en...

Erratum to "Surgical outcomes in the treatment of temporal bone cerebrospinal fluid leak: A systematic review" Auris Nasus Larynx 45 (2018) 903-910.

Clinical Trials [3198 Associated Clinical Trials listed on BioPortfolio]

Phase III Open Study, Prospective, Multicenter, Randomized, Comparative to the Positive Control for Evaluating the Efficacy and Safety of Auris-Sedina in the Symptomatic Control of Otalgy in Patients With or Without Acute External Otitis.

To evaluate the efficacy and tolerability of Auris-Sedina in the symptomatic control of otalgy in patients with and without acute external otitis compared with use of Otosynalar®.

Open-Label Study to Evaluate the Efficacy and Safety of SCY-078 in Patients With Candidiasis Caused by Candida Auris (CARES)

This is a multicenter, open-label, non-comparator, single-arm study to evaluate the efficacy, safety, tolerability and PK (pharmacokinetics) of oral SCY-078 as an emergency use treatment f...

Auris Robotic Endoscopy System for Bronchoscopy

In this study, the performance related to the use of the novel Robotic Endoscopy Platform during bronchoscopic procedures will be evaluated.

Health Literacy in the General Population in Belgium

The aims of the study are: - To measure health literacy (HL) levels in a sample composed of members of a health mutual (Solidaris), and its potential associations with several det...

Evaluation of Health Education Theater

This study evaluates the feasibility and the potential positive health impacts of a novel "health education theater," which will task participants of a health education program to create a...

Companies [1810 Associated Companies listed on BioPortfolio]

Auris Health, Inc.

Based in Silicon Valley, Auris Health is pioneering the next era of medical intervention by developing platforms that enhance physician capabilities, evolve minimally invasive tec...

Innovation Health

Innovation Health provides health benefit plans to more than 200,000 members. The product of a unique Aetna and Inova Health System partnership, Innovation Heal...

Health Net Foundation

Based in Woodland Hills, Calif., the Health Net Foundation was created in 2007 as a philanthropic arm of Health Net, Inc. (NYSE: HNT), one of the nation’s largest publicly tr...

Health Net Community Solutions, Inc. and CalViva Health

Health Net Community Solutions, Inc. is a subsidiary of Health Net of California, Inc., which is a subsidiary of Health Net, Inc. (NYSE: HNT) and one of the largest health plans i...

Broward Health Medical Center

Broward Health, providing service for more than 80 years, is a nationally recognized system in South Florida that offers world-class healthcare to all. The Broward Health system i...

More Information about "Auris Health, Inc." on BioPortfolio

We have published hundreds of Auris Health, Inc. news stories on BioPortfolio along with dozens of Auris Health, Inc. Clinical Trials and PubMed Articles about Auris Health, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Auris Health, Inc. Companies in our database. You can also find out about relevant Auris Health, Inc. Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record